Status:
COMPLETED
An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery
Lead Sponsor:
Bio Products Laboratory
Conditions:
Haemophilia B
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The main objectives of this study were to investigate the safety and efficacy of Replenine®-VF administered in appropriate dosage by bolus infusion to prevent bleeding and achieve haemostasis in subje...
Eligibility Criteria
Inclusion
- Subjects with moderate to severe haemophilia B undergoing major surgery requiring an in-patient stay of generally 5 to 10 days.
Exclusion
- \-
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02250573
Start Date
December 1 2005
Last Update
February 22 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Samodzielny Publiczny Zaklad Opieki Zdrowotnej nad Matka I Dzieckiem, ul. Krysiewicza 7/8.
Poznan, Poland, 61-825
2
Institutul National de Haemtologie, 2-8 Constantin Caracas Str.
Bucharest, Romania
3
Spitalul de urgenta pentru copii "Louis Turcana", Str. losef Nemoianu 2.
Timișoara, Romania
4
Kirov Research Institute of Haematology, 72 Krasnoarmeyskaya ul.
Kirov, Russia, 610027